Ryan presents her data in breast cancer at AACR conference
Ryan presents her data on SMYD2 regulating the chromatin modifier KMT2D in breast cancer at AACR conference 2022 in New Orleans
Christopher Simpkins joins the Toska Lab
Christopher Simpkins joins the Toska Lab to pursue his PhD (May 2022)
Toska Lab is Partner of Choice with Astrazeneca Pharmaceuticals
Toska lab gets selected as Partner of Choice for a grant with Astrazeneca Pharmaceuticals
PI3K-mediated splicing in breast cancer is published in Cancer Research
Our paper on PI3K-mediated splicing in breast cancer is published in Cancer Research (March, 2022). Congrats to Ryan, Srushti, Adler, and Yuhan from the Toska Lab. See the publication here: https://aacrjournals.org/cancerres/article/82/12/2269/699352/The-Oncogenic-PI3K-Induced-Transcriptomic
Eneda awarded an R21 grant from NCI
Eneda gets awarded an R21 grant from NCI on the role of SWI/SNF complex in endocrine therapy resistance.